Status:
UNKNOWN
The Effects of Fenugreek Extract (Fenobet) on Metabolic Syndrome
Lead Sponsor:
Tehran University of Medical Sciences
Conditions:
Metabolic Syndrome
Complementary Therapies
Eligibility:
All Genders
20-60 years
Phase:
NA
Brief Summary
The current study is a three-blind, randomized clinical trial study that will be conducted on 60 people with metabolic syndrome. The eligible participants were allocated randomly to one of the two stu...
Detailed Description
The current study is a three-blind, randomized clinical trial study that will be conducted on 60 people with metabolic syndrome. According to the ATP criteria, a person who has at least 3 of the follo...
Eligibility Criteria
Inclusion
- People with metabolic syndrome
- Fasting sugar above 100 mg/dL
- Both men and women
- Age range 20-60 years
Exclusion
- Injection of insulin or liraglutide
- People under 20 years old and over 60 years old
- having chronic cardiovascular diseases, chronic liver and kidney diseases, uncontrolled thyroid disorders and malignancies including cancer
- Taking herbal medicines or herbs to control blood sugar and fat in the last 6 months
- Patients who are treated with a special diet such as vegetarianism or a special exercise program.
- Allergy
- Pregnant and lactating women
Key Trial Info
Start Date :
November 1 2023
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
February 20 2024
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT06114134
Start Date
November 1 2023
End Date
February 20 2024
Last Update
November 2 2023
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.